Excluding Excise Duty and Other Income, represents Net Revenue
Hester Biosciences Ltd revenue growth forecast
Expected growth rate Q1, FY2023:0.94%
Forecast
Actual
Including amortisation and stock based compensations
Hester Biosciences Ltd EPS growth forecast
EPS estimate Q1, FY2023:13.74%
Forecast
Actual
Source: S&P Global Market Intelligence
Day's Low
Day's High
52 Week's Low
52 Week's High
Returns % | |
1 Month Return | -8.47 % |
3 Month Return | -7.62 % |
1 Year Return | + 44.09 % |
Market Stats | |
Previous Close | ₹2,194.65 |
Open | ₹2,186.85 |
Volume | 2,732.00 |
Upper Circuit | - |
Lower Circuit | - |
Market Cap | ₹1,866.96Cr |
P/E Ratio | 71.94 |
PEG Ratio | -26.26 |
Market Cap | ₹1,866.96 Cr |
P/B Ratio | 3.78 |
EPS | 24.88 |
Dividend Yield | 0.43 |
Sector | Pharmaceuticals |
ROE | 8.98 |
Company | Analyst View | Market Cap | 5 Year CAGR | Debt to Asset Ratio | Net Profit | Yearly Revenue |
---|---|---|---|---|---|---|
NA | ₹1,866.96 Cr | 7.61% | 0.69 | ₹21 Cr | ₹304 Cr | |
NA | ₹10.17 Cr | 94.34% | 0.88 | NA | NA | |
NA | ₹261.26 Cr | 97.58% | 0.52 | ₹16 Cr | ₹108 Cr | |
NA | ₹122.53 Cr | 40.58% | 0.51 | NA | NA | |
NA | ₹14,909.73 Cr | -1.26% | 0.73 | ₹82 Cr | ₹1,465 Cr |
Organisation | Hester Biosciences Ltd |
Headquarters | |
Industry | Pharmaceuticals |
E-voting on shares | Click here to vote |
Key events for Hester Biosciences Ltd
Hester Biosciences Reports Strong Q2 FY25 Earnings - 28 Oct, 2024
Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.
Profit Spike
Netprofit is up for the last 4 quarters, 3.98 Cr → 8.2 Cr (in ₹), with an average increase of 21.4% per quarter
Retail Holding Up
Retail Investor have increased holdings from 45.64% to 45.65% in Dec 2024 quarter
Revenue Rich
Revenue is up for the last 4 quarters, 69.18 Cr → 86.49 Cr (in ₹), with an average increase of 6.9% per quarter
Against Peers
In the last 1 year, Divis Laboratories Ltd has given 46.6% return, outperforming this stock by 5.0%
Promoter Holding Unchanged
Promoters holdings remained unchanged at 53.73% of holdings in Dec 2024 quarter
Against Peers
In the last 3 years, Sun Pharmaceuticals Industries Ltd has given 103.2% return, outperforming this stock by 115.2%
Price Dip
In the last 6 months, HESTERBIO stock has moved down by -20.7%
FII Holding Down
Foreign Institutions have decreased holdings from 0.61% to 0.59% in Dec 2024 quarter
Investors | Holdings % | FY Quarter | 3M change |
---|---|---|---|
Promoter Holdings | 53.73% | 0.00 | |
Foreign Institutions | 0.59% | ||
Mutual Funds | 0% | 30.77 | |
Retail Investors | 45.65% | 0.03 | |
Others | 0.02% | 0.57 |
Hester Biosciences Ltd in the last 5 years
Lowest (19.52x)
March 23, 2020
Industry (54.95x)
January 17, 2025
Today (71.94x)
January 17, 2025
Highest (124.52x)
July 26, 2024
Hester Biosciences Ltd’s net profit jumped 100.49% since last year same period to ₹8.20Cr in the Q2 2024-2025. On a quarterly growth basis, Hester Biosciences Ltd has generated 29.34% jump in its net profits since last 3-months.
Read More about Earnings ResultsIn the quarter ending March 2024, Hester Biosciences Ltd has declared dividend of ₹6 - translating a dividend yield of 0.63%.
Read More about DividendsBearish
Neutral
Bullish
Hester Biosciences Ltd is currently in a Bearish trading position according to technical analysis indicators.
Hester Biosciences Ltd share price today stands at ₹2223.65, Open. ₹2186.85 ; Previous Close. ₹2194.65 ; High. ₹2261.85 ; Low. ₹2179.9 ; 52 Week High. ₹3379 ; 52 Week Low: ₹1292.85.
Hester Biosciences Ltd is listed on NSE
Hester Biosciences Ltd is listed on BSE
PE Ratio of Hester Biosciences Ltd is 71.94
PE ratio = Hester Biosciences Ltd Market price per share / Hester Biosciences Ltd Earnings per share
Today’s traded volume of Hester Biosciences Ltd(HESTERBIO) is 2,732.00.
Today’s market capitalisation of Hester Biosciences Ltd(HESTERBIO) is ₹1866.96Cr.
Hester Biosciences Ltd(HESTERBIO | Price |
---|---|
52 Week High | ₹3379 |
52 Week Low | ₹1292.85 |
Hester Biosciences Ltd(HESTERBIO) share price is ₹2223.65. It is down -34.19% from its 52 Week High price of ₹3379
Hester Biosciences Ltd(HESTERBIO) share price is ₹2223.65. It is up 72.00% from its 52 Week Low price of ₹1292.85
Hester Biosciences Ltd(HESTERBIO | Returns |
---|---|
1 Day Returns | 29% |
1 Month Returns | -8.47% |
3 Month Returns | -7.62% |
1 Year Returns | 44.09% |